Kidney stone treatment
Reading File
Now let me search the library and PubMed in parallel for comprehensive kidney stone treatment coverage.
Finding Sources
Searching PubMed
"nephrolithiasis" AND "treatment"
Finding Sources
Finding Sources
Excellent — I have multiple relevant sources. Let me read the key sections in parallel.
Reading File
Reading File
Reading File
Good content from Harrison's and Campbell-Walsh. Let me read more of Harrison's and the Brenner & Rector pharmacology sections.
Reading File
Reading File
I now have rich, comprehensive content. Let me compile the full answer.
Kidney Stone (Nephrolithiasis) Treatment
1. Acute Management (Passing a Stone)
Pain Relief
The priority in acute renal colic is analgesia. NSAIDs (e.g., ketorolac, ibuprofen) are first-line; opioids are used when NSAIDs are insufficient or contraindicated. IV hydration is given when the patient cannot tolerate oral fluids.
Medical Expulsive Therapy (MET)
α-blockers (e.g., tamsulosin) and calcium channel blockers reduce dysmotile ureteric contractions while preserving expulsive peristaltic activity, facilitating stone passage — particularly for distal ureteral stones ≤10 mm.
When to Intervene Urgently
A UTI in the setting of ureteral obstruction is a medical emergency requiring immediate drainage via ureteral stent or percutaneous nephrostomy tube. Other indications for urgent intervention: intractable pain/vomiting, solitary kidney, bilateral obstruction, AKI.
2. Surgical / Procedural Treatment
Treatment selection depends primarily on stone size, location, composition (CT attenuation), and patient anatomy.
Stone Burden Classification (Campbell-Walsh Urology)
| Stone Size | Preferred Approach |
|---|---|
| ≤1 cm | SWL (first-line) or flexible URS (equally acceptable, per EAU/AUA guidelines) |
| 1–2 cm | SWL or URS; PCNL if lower-pole or high-attenuation |
| >2 cm | PCNL preferred; SWL/URS may be used adjunctively |
| Staghorn calculi | PCNL (often staged) |
Extracorporeal Shock Wave Lithotripsy (ESWL)
- Non-invasive; fragments stones <2 cm using focused high-energy shock waves
- Stone-free rates: ~80–88% for renal pelvis/UPJ stones, ~70% for upper/mid calyces, only 35–69% for lower pole stones
- Less effective for: stones with CT attenuation ≥900 HU, lower-pole location, obesity, anatomic anomalies
- Contraindications: pregnancy, uncorrected coagulopathy, aortic aneurysm, distal obstruction
Ureteroscopy (URS) / Retrograde Intrarenal Surgery (RIRS)
- Flexible URS now a co-equal first-line option for stones ≤1 cm (EAU/AUA guidelines)
- Laser lithotripsy (holmium or thulium fiber laser) fragments the stone for retrieval or dusting
- Avoids ionizing radiation concerns; useful when SWL is contraindicated
- Generally avoided in children <5 years
Percutaneous Nephrolithotomy (PCNL)
- Gold standard for stones >2 cm, lower-pole stones, ESWL-refractory stones, staghorn calculi
- Creates a dilated percutaneous tract into the kidney for stone extraction
- Higher stone-free rates than SWL/URS for large stones, but more invasive with higher complication risk (bleeding, infection)
- Mini-PCNL, ultra-mini, and micro-PCNL variants available for smaller stones
Open/Laparoscopic Surgery
- Rarely necessary; reserved for anatomic abnormalities (e.g., ureteropelvic junction obstruction requiring simultaneous repair) where endoscopic approaches fail
3. Stone-Type-Specific Medical Prevention
Calcium Oxalate Stones (most common, ~80%)
| Intervention | Mechanism |
|---|---|
| High fluid intake (>2.5 L/day urine output) | Reduces urinary supersaturation |
| Normal dietary calcium (1000–1200 mg/day with meals) | Binds intestinal oxalate, reduces absorption |
| Low sodium (<2.5 g/day) | Reduces urinary calcium excretion |
| Low animal protein | Reduces Ca excretion, increases citrate |
| Thiazide diuretics (e.g., hydrochlorothiazide, chlorthalidone) | Reduces urinary Ca by ~50%; requires dietary Na restriction |
| Potassium citrate | Raises urinary citrate (natural inhibitor); alkalinizes urine |
| Allopurinol | Reduces stone recurrence in those with hyperuricosuria + CaOx stones |
Avoid: high-dose vitamin C supplements (increases endogenous oxalate), high-oxalate foods (spinach, rhubarb, almonds), calcium supplements outside of meals.
Calcium Phosphate Stones
- Urine pH is the key driver (forms at pH >6.5)
- Thiazides to reduce hypercalciuria; avoid excessive alkali therapy
- Evaluate for primary hyperparathyroidism, distal RTA
Uric Acid Stones
- Urine alkalinization to pH 6.0–6.5 (potassium citrate or sodium bicarbonate) is highly effective — can dissolve existing stones
- Reduce purine-rich foods; allopurinol if hyperuricemia/hyperuricosuria persists
- Increase fluid intake
Struvite (Infection) Stones
- Caused by urease-producing bacteria (Proteus mirabilis, Klebsiella)
- Complete surgical removal is essential (PCNL) — fragments left behind perpetuate infection
- Antibiotics targeted to the organism
- Acetohydroxamic acid (AHA) — urease inhibitor — used in refractory cases
Cystine Stones
- Very high fluid intake (~4 L/day including nocturnal) to keep cystine <243 mg/L
- Urine alkalinization to pH >7.0 (potassium citrate)
- D-penicillamine or tiopronin (α-mercaptopropionylglycine) — chelating agents that increase cystine solubility
- These stones are often ESWL-resistant; PCNL or URS preferred
Primary Hyperoxaluria (Type I)
- Lumasiran or nedosiran — siRNA-based therapies that reduce hepatic oxalate generation (approved in recent years)
4. General Preventive Measures (All Stone Types)
- Fluid intake: Target >2.5 L/day urine output; distribute throughout the day and at night
- Dietary calcium: Normal intake (1000–1200 mg/day) — restriction is harmful, not protective
- Low sodium: <2.5 g/day reduces calciuria
- Moderate animal protein: Reduces calciuria and increases citruria
- DASH-style diet (high fruit/vegetable, low animal protein): Associated with reduced stone risk
- Metabolic workup after first stone (especially in high-risk patients): 24-hour urine collection for calcium, oxalate, citrate, uric acid, sodium, volume
5. Special Populations
- Children: Ultrasound preferred for imaging (avoids radiation); MET and ESWL/URS/PCNL used based on size; full metabolic workup mandatory
- Pregnancy: ESWL contraindicated; URS is safest procedural option; conservative management first
- Solitary kidney / bilateral obstruction: Lower threshold for urgent drainage
Sources:
- Harrison's Principles of Internal Medicine, 22e (2025), Ch. 330: Nephrolithiasis
- Campbell-Walsh-Wein Urology, Ch. 93: Treatment Decision by Stone Burden
- Brenner & Rector's The Kidney — Urolithiasis, Dietary & Pharmacologic Management
- Bailey and Love's Short Practice of Surgery, 28e — Urolithiasis
Recent evidence (2024–2026):
- A 2026 systematic review in Annals of Internal Medicine specifically addresses prevention of recurrent nephrolithiasis in adults and children (PMID 41871357) — consistent with the dietary and pharmacologic strategies above.
This is a shared conversation. Sign in to Orris to start your own chat.